Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Antonio Llombart
Universidad Católica de Salta
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
26
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Positioning of Tucatinib in the New Clinical Scenario of HER2-Positive Metastatic Breast Cancer: An Italian and Spanish Consensus Paper
Number of pages: 18
Posted: 19 Mar 2024
Pierfranco Conte
,
Eva Ciruelos
,
Giuseppe Curigliano
,
Michelino De Laurentiis
,
Lucia Del Mastro
,
Alessandra Gennari
, Antonio Llombart,
Miguel Martin
,
Francesca Poggio
,
Aleix Prat
,
Fabio Puglisi
and
Cristina Saura
Istituto Oncologico Veneto – IRCCS, SOLTI Breast Cancer Research Group, European Institute of Oncology (IEO) IRCCS - Division of New Drugs and Early Drug Development for Innovative Therapies, IRCCS-Fondazione Bietti, University of Genova - Department of Internal Medicine and Medical Specialties (DiMI), University of Piemonte Orientale, Universidad Católica de Salta, - Hospital General Universitario Gregorio Marañón, IRCCS Ospedale Policlinico San Martino, Hospital Clinic of Barcelona - Department of Medical Oncology, Università degli Studi di Udine and Vall d’Hebron Institute of Oncology (VHIO)
Downloads
26
(1,372,601)
View PDF
Download
Abstract:
breast cancer, HER2, tucatinib, TKI, brain metastases
Feedback